A potent, selective, and orally bioavailable ATP-competitive mTOR kinase inhibitor with an IC50 of 0.8 nM. It inhibits the phosphorylation of mTORC1 substrates p70S6K and 4E-BP1 as well as phosphorylation of the mTORC2 substrate AKT and downstream proteins. The rapamycin-resistant T37/46 phosphorylation sites on 4E-BP1 were fully inhibited by AZD8055, resulting in significant inhibition of cap-dependent translation. In vitro, AZD8055 potently inhibits proliferation and induces autophagy in H838 and A549 cells. In vivo, AZD8055 induces a dose-dependent pharmacodynamic effect on phosphorylated S6 and phosphorylated AKT at plasma concentrations leading to tumor growth inhibition.
Payment
eBioChem Escrow service is especially designed for online transaction. You, as a buyer, will pay the Supplier ONLY after you receive the item(s) and are satisfied with the item(s). This value-added service is absolutely FREE and is available for all transactions at eBioChem.com.
Payment Method
Alipay:
Alipay can support the domestic Union pay card with RMB payment
payPal:
Credit Card:
Paypal can support all of the foreign credit card payment
